Armstrong World Industries Inc (AWI) stock
Close on Nov 17, 2026Market cap $7.21BP/E 23.0Yield 0.73%
Earnings
Armstrong World Industries's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of Armstrong World Industries's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q4 FY2026ended Dec 31, 2026 | Feb 23, 2027Expected | – | – | – | – | – |
| Q3 FY2026ended Sep 30, 2026 | Oct 27, 2026before the open | $475.80M | +11.9% | $2.17 | $2.26 | Release |
| Q2 FY2026ended Jun 30, 2026 | Jul 28, 2026before the open | $472.00M | +11.2% | $2.26 | $2.36 | Release |
| Q1 FY2026ended Mar 31, 2026 | Apr 28, 2026before the open | $409.90M | +7.1% | $1.55 | $1.69 | Release |
| Q4 FY2025ended Dec 31, 2025 | Feb 24, 2026before the open | $388.30M | +5.6% | $1.51 | $1.61 | Release |
| Q3 FY2025ended Sep 30, 2025 | Oct 28, 2025before the open | $425.20M | +10.0% | $1.98 | $2.05 | Release |
| Q2 FY2025ended Jun 30, 2025 | Jul 29, 2025before the open | $424.60M | +16.3% | $2.01 | $2.09 | Release |
| Q1 FY2025ended Mar 31, 2025 | Apr 29, 2025before the open | $382.70M | +17.3% | $1.58 | $1.66 | Release |
| Q4 FY2024ended Dec 31, 2024 | Feb 25, 2025before the open | $367.70M | +17.7% | $1.42 | $1.50 | Release |
| Q3 FY2024ended Sep 30, 2024 | Oct 29, 2024before the open | $386.60M | +11.3% | $1.75 | $1.81 | Release |
| Q2 FY2024ended Jun 30, 2024 | Jul 30, 2024before the open | $365.10M | +12.2% | $1.50 | $1.62 | Release |
| Q1 FY2024ended Mar 31, 2024 | Apr 30, 2024before the open | $326.30M | +5.2% | $1.36 | $1.38 | Release |
| Q4 FY2023ended Dec 31, 2023 | Feb 20, 2024before the open | $312.30M | +2.6% | $1.06 | $1.22 | Release |
| Q3 FY2023ended Sep 30, 2023 | Oct 24, 2023before the open | $347.30M | +6.9% | $1.56 | $1.60 | Release |
| Q2 FY2023ended Jun 30, 2023 | Jul 25, 2023before the open | $325.40M | +1.4% | $1.34 | $1.38 | Release |
| Q1 FY2023ended Mar 31, 2023 | Apr 25, 2023before the open | $310.20M | +9.8% | $1.04 | $1.12 | Release |
| Q4 FY2022ended Dec 31, 2022 | Feb 21, 2023before the open | $304.50M | +7.8% | $1.07 | $1.08 | Release |
| Q3 FY2022ended Sep 30, 2022 | Oct 25, 2022before the open | $325.00M | +11.2% | $1.18 | $1.36 | Release |
| Q2 FY2022ended Jun 30, 2022 | Jul 26, 2022before the open | $321.00M | – | $1.11 | $1.29 | Release |
| Q1 FY2022ended Mar 31, 2022 | Apr 26, 2022before the open | $282.60M | – | $0.94 | $1.02 | Release |
| Q4 FY2021ended Dec 31, 2021 | Feb 22, 2022before the open | $282.50M | – | $0.88 | $1.09 | Release |
| Q3 FY2021ended Sep 30, 2021 | Oct 26, 2021before the open | $292.20M | – | $1.06 | $1.17 | Release |
| Q2 FY2021ended Jun 30, 2021 | Jul 27, 2021before the open | – | – | – | – | Filing |
| Q1 FY2021ended Mar 31, 2021 | Apr 27, 2021before the open | – | – | – | – | Filing |
| Q4 FY2020ended Dec 31, 2020 | Feb 23, 2021before the open | – | – | – | – | Filing |
| Q3 FY2020ended Sep 30, 2020 | Oct 27, 2020before the open | – | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
Armstrong World Industries's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| Net salesGAAP | FY2026 | $1.79B – $1.80B | – | New | Oct 27, 2026 |
| Net sales | FY2026 | $1.77B – $1.80B | $1.75B – $1.79B | Raised | Jul 28, 2026 |
| Net salesGAAP | FY2026 | $1.75B – $1.79B | – | New | Apr 28, 2026 |
| Net sales VPY Growth % | FY2026 | +9% – +11% | +8% – +10% | Raised | Jul 28, 2026 |
| Operating incomeGAAP | FY2026 | $477.00M – $487.00M | $479.00M – $494.00M | Lowered | Jul 28, 2026 |
| Adjusted EBITDAnon-GAAP | FY2026 | $602.00M – $612.00M | – | New | Oct 27, 2026 |
| Adjusted EBITDAnon-GAAP | FY2026 | $605.00M – $620.00M | $600.00M – $620.00M | Raised | Jul 28, 2026 |
| Adjusted EBITDA VPY Growth %non-GAAP | FY2026 | +9% – +12% | +8% – +12% | Raised | Jul 28, 2026 |
| Net earnings Per Diluted ShareGAAP | FY2026 | $7.99 – $8.14 | $7.84 – $8.07 | Raised | Jul 28, 2026 |
| Adjusted diluted net earnings per sharenon-GAAP | FY2026 | $8.30 – $8.40 | – | New | Oct 27, 2026 |
| Adjusted diluted net earnings per sharenon-GAAP | FY2026 | $8.30 – $8.50 | $8.15 – $8.45 | Raised | Jul 28, 2026 |
| Adjusted diluted net earnings per share VPY Growth %non-GAAP | FY2026 | +12% – +15% | +9% – +13% | Raised | Jul 28, 2026 |
| Adjusted free cash flownon-GAAP | FY2026 | $380.00M – $390.00M | – | New | Oct 27, 2026 |
| Adjusted free cash flownon-GAAP | FY2026 | $380.00M – $395.00M | $375.00M – $395.00M | Raised | Jul 28, 2026 |
| Adjusted free cash flow VPY Growth %non-GAAP | FY2026 | +10% – +14% | +9% – +14% | Raised | Jul 28, 2026 |
| Capital expenditures | FY2026 | $100.00M – $110.00M | – | New | Jul 28, 2026 |
| Capital expendituresGAAP | FY2026 | $100.00M – $110.00M | – | New | Feb 24, 2026 |
| Net earningsGAAP | FY2026 | $339.00M – $345.00M | – | New | Jul 28, 2026 |
Guidance vs results
The last range Armstrong World Industries gave before each report, against the figure it then reported. Full years add up the four quarters.
| Period | Metric | Guidance | Actual | Result |
|---|---|---|---|---|
| FY2025 | Adjusted diluted net earnings per share | $7.45 – $7.55 | $7.41Σ4Q | Below range |
| FY2025 | EPS (GAAP) | $7.19 – $7.24 | $7.08Σ4Q | Below range |
| FY2025 | Revenue | $1.62B – $1.64B | $1.62BΣ4Q | Below range |
| FY2025 | Revenue growth | +12% – +13% | +12.11%Σ4Q | Within range |
Guidance history
Every forecast Armstrong World Industries put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Oct 27, 2026 | Adjusted EBITDA | FY2026 | $602.00M – $612.00M | New |
| Oct 27, 2026 | Adjusted diluted net earnings per share | FY2026 | $8.30 – $8.40 | New |
| Oct 27, 2026 | Adjusted free cash flow | FY2026 | $380.00M – $390.00M | New |
| Oct 27, 2026 | Net sales | FY2026 | $1.79B – $1.80B | New |
| Jul 28, 2026 | Capital expenditures | FY2026 | $100.00M – $110.00M | New |
| Jul 28, 2026 | Adjusted EBITDA | FY2026 | $605.00M – $620.00M | Raised |
| Jul 28, 2026 | Adjusted EBITDA VPY Growth % | FY2026 | +9% – +12% | Raised |
| Jul 28, 2026 | Adjusted diluted net earnings per share VPY Growth % | FY2026 | +12% – +15% | Raised |
| Jul 28, 2026 | Adjusted diluted net earnings per share | FY2026 | $8.30 – $8.50 | Raised |
| Jul 28, 2026 | Net earnings Per Diluted Share | FY2026 | $7.99 – $8.14 | Raised |
| Jul 28, 2026 | Adjusted free cash flow | FY2026 | $380.00M – $395.00M | Raised |
| Jul 28, 2026 | Adjusted free cash flow VPY Growth % | FY2026 | +10% – +14% | Raised |
| Jul 28, 2026 | Operating income | FY2026 | $477.00M – $487.00M | Lowered |
| Jul 28, 2026 | Net earnings | FY2026 | $339.00M – $345.00M | New |
| Jul 28, 2026 | Net sales | FY2026 | $1.77B – $1.80B | Raised |
| Jul 28, 2026 | Net sales VPY Growth % | FY2026 | +9% – +11% | Raised |
| Apr 28, 2026 | Adjusted EBITDA | FY2026 | $600.00M – $620.00M | Reaffirmed |
| Apr 28, 2026 | Adjusted diluted net earnings per share | FY2026 | $8.15 – $8.45 | Raised |
| Apr 28, 2026 | Adjusted free cash flow | FY2026 | $375.00M – $395.00M | Reaffirmed |
| Apr 28, 2026 | Net sales | FY2026 | $1.75B – $1.79B | New |
| Feb 24, 2026 | Capital expenditures | FY2026 | $100.00M – $110.00M | New |
| Feb 24, 2026 | Adjusted EBITDA | FY2026 | $600.00M – $620.00M | New |
| Feb 24, 2026 | Adjusted EBITDA VPY Growth % | FY2026 | +8% – +12% | New |
| Feb 24, 2026 | Adjusted diluted net earnings per share VPY Growth % | FY2026 | +9% – +13% | New |
| Feb 24, 2026 | Adjusted diluted net earnings per share | FY2026 | $8.05 – $8.35 | New |
| Feb 24, 2026 | Net earnings Per Diluted Share | FY2026 | $7.84 – $8.07 | New |
| Feb 24, 2026 | Adjusted free cash flow VPY Growth % | FY2026 | +9% – +14% | New |
| Feb 24, 2026 | Adjusted free cash flow | FY2026 | $375.00M – $395.00M | New |
| Feb 24, 2026 | Operating income | FY2026 | $479.00M – $494.00M | New |
| Feb 24, 2026 | Net sales | FY2026 | $1.75B – $1.79B | New |
| Feb 24, 2026 | Net sales VPY Growth % | FY2026 | +8% – +10% | New |
| Oct 28, 2025 | Capital expenditures | FY2025 | $105.00M – $110.00M | New |
| Oct 28, 2025 | Adjusted EBITDA | FY2025 | $553.00M – $563.00M | New |
| Oct 28, 2025 | Adjusted EBITDA VPY Growth % | FY2025 | +14% – +16% | New |
| Oct 28, 2025 | Adjusted diluted net earnings per share | FY2025 | $7.45 – $7.55 | New |
| Oct 28, 2025 | Adjusted diluted net earnings per share VPY Growth % | FY2025 | +18% – +20% | New |
| Oct 28, 2025 | Net earnings per Diluted Share | FY2025 | $7.19 – $7.24 | New |
| Oct 28, 2025 | Adjusted free cash flow VPY Growth % | FY2025 | +15% – +18% | New |
| Oct 28, 2025 | Adjusted free cash flow | FY2025 | $342.00M – $352.00M | New |
| Oct 28, 2025 | Operating income | FY2025 | $434.00M – $441.00M | New |
| Oct 28, 2025 | Net sales VPY Growth % | FY2025 | +12% – +13% | New |
| Oct 28, 2025 | Net sales | FY2025 | $1.62B – $1.64B | New |
| Jul 29, 2025 | Capital expenditures | FY2025 | $100.00M – $110.00M | New |
| Jul 29, 2025 | Adjusted EBITDA | FY2025 | $545.00M – $560.00M | Raised |
| Jul 29, 2025 | Adjusted diluted net earnings per share | FY2025 | $7.15 – $7.30 | Raised |
| Jul 29, 2025 | Net earnings per diluted share | FY2025 | $6.93 – $6.99 | Raised |
| Jul 29, 2025 | Adjusted free cash flow | FY2025 | $330.00M – $345.00M | Raised |
| Jul 29, 2025 | Operating income | FY2025 | $425.00M – $436.00M | Raised |
| Jul 29, 2025 | Net sales | FY2025 | $1.60B – $1.63B | Raised |
| Apr 29, 2025 | Capital expenditures | FY2025 | $90.00M – $100.00M | Reaffirmed |
| Apr 29, 2025 | Adjusted EBITDA | FY2025 | $525.00M – $545.00M | Reaffirmed |
| Apr 29, 2025 | Adjusted EBITDA VPY Growth % | FY2025 | +8% – +12% | New |
| Apr 29, 2025 | Adjusted diluted net earnings per share | FY2025 | $6.85 – $7.15 | Reaffirmed |
| Apr 29, 2025 | Adjusted diluted net earnings per share VPY Growth % | FY2025 | +9% – +13% | New |
| Apr 29, 2025 | Diluted net earnings per share | FY2025 | $6.63 – $6.77 | Lowered |
| Apr 29, 2025 | Adjusted free cash flow | FY2025 | $315.00M – $335.00M | Reaffirmed |
| Apr 29, 2025 | Adjusted free cash flow VPY Growth % | FY2025 | +6% – +12% | New |
| Apr 29, 2025 | Operating income | FY2025 | $409.00M – $423.00M | Reaffirmed |
| Apr 29, 2025 | Adjusted operating income | FY2025 | $410.00M – $425.00M | New |
| Apr 29, 2025 | Net cash provided by operating activities | FY2025 | $297.00M – $319.00M | Raised |
| Apr 29, 2025 | Net earnings | FY2025 | $289.00M – $293.00M | New |
| Apr 29, 2025 | Net sales VPY Growth % | FY2025 | +9% – +11% | New |
| Apr 29, 2025 | Net sales | FY2025 | $1.57B – $1.61B | Reaffirmed |
| Feb 25, 2025 | Capital expenditures | FY2025 | $90.00M – $100.00M | New |
| Feb 25, 2025 | Adjusted EBITDA | FY2025 | $525.00M – $545.00M | New |
| Feb 25, 2025 | Adjusted diluted net earnings per share | FY2025 | $6.85 – $7.15 | New |
| Feb 25, 2025 | Net earnings per diluted share | FY2025 | $6.72 – $6.84 | New |
| Feb 25, 2025 | Adjusted free cash flow | FY2025 | $315.00M – $335.00M | New |
| Feb 25, 2025 | Operating income | FY2025 | $409.00M – $423.00M | New |
| Feb 25, 2025 | Net sales | FY2025 | $1.57B – $1.61B | New |
| Oct 29, 2024 | Capital expenditures | FY2024 | $82.00M – $88.00M | New |
| Oct 29, 2024 | Adjusted EBITDA | FY2024 | $482.00M – $490.00M | Raised |
| Oct 29, 2024 | Adjusted EBITDA VPY Growth % | FY2024 | +12% – +14% | New |
| Oct 29, 2024 | Adjusted diluted net earnings per share | FY2024 | $6.15 – $6.25 | Raised |
| Oct 29, 2024 | Adjusted diluted net earnings per share VPY Growth % | FY2024 | +16% – +17% | New |
| Oct 29, 2024 | Net earnings Per Diluted Share | FY2024 | $5.91 – $5.95 | New |
| Oct 29, 2024 | Adjusted free cash flow VPY Growth % | FY2024 | +10% – +14% | New |
| Oct 29, 2024 | Adjusted free cash flow | FY2024 | $290.00M – $300.00M | Raised |
| Oct 29, 2024 | Operating income | FY2024 | $372.00M – $377.00M | New |
| Oct 29, 2024 | Net sales VPY Growth % | FY2024 | +10% – +11% | New |
| Oct 29, 2024 | Net sales | FY2024 | $1.42B – $1.44B | New |
| Jul 30, 2024 | Adjusted EBITDA | FY2024 | $474.00M – $486.00M | Raised |
| Jul 30, 2024 | Adjusted diluted net earnings per share | FY2024 | $6.00 – $6.15 | Raised |
| Jul 30, 2024 | Adjusted free cash flow | FY2024 | $288.00M – $300.00M | Raised |
| Jul 30, 2024 | Net sales | FY2024 | $1.42B – $1.44B | Raised |
| Apr 30, 2024 | Adjusted EBITDA | FY2024 | $465.00M – $485.00M | Raised |
| Apr 30, 2024 | Adjusted diluted net earnings per share | FY2024 | $5.80 – $6.05 | Raised |
| Apr 30, 2024 | Adjusted free cash flow | FY2024 | $285.00M – $300.00M | Raised |
| Apr 30, 2024 | Net sales | FY2024 | $1.40B – $1.44B | Raised |
| Feb 20, 2024 | Adjusted EBITDA | FY2024 | $450.00M – $470.00M | New |
| Feb 20, 2024 | Adjusted diluted net earnings per share | FY2024 | $5.60 – $5.90 | New |
| Feb 20, 2024 | Adjusted free cash flow | FY2024 | $275.00M – $290.00M | New |
| Feb 20, 2024 | Net sales | FY2024 | $1.34B – $1.38B | New |
| Oct 24, 2023 | Adjusted EBITDA | FY2023 | $418.00M – $426.00M | Raised |
| Oct 24, 2023 | Adjusted diluted net earnings per share | FY2023 | $5.05 – $5.15 | Raised |
| Oct 24, 2023 | Adjusted free cash flow | FY2023 | $245.00M – $255.00M | Raised |
| Oct 24, 2023 | Net sales | FY2023 | $1.28B – $1.30B | Narrowed |
| Jul 25, 2023 | Adjusted EBITDA | FY2023 | $400.00M – $420.00M | Raised |
| Jul 25, 2023 | Adjusted diluted net earnings per share | FY2023 | $4.85 – $5.05 | Raised |
| Jul 25, 2023 | Adjusted free cash flow | FY2023 | $240.00M – $250.00M | Raised |
| Jul 25, 2023 | Net sales | FY2023 | $1.27B – $1.31B | Narrowed |
| Apr 25, 2023 | Capital expenditures | FY2023 | $75.00M – $85.00M | New |
| Apr 25, 2023 | Adjusted EBITDA | FY2023 | $395.00M – $420.00M | Reaffirmed |
| Apr 25, 2023 | Adjusted diluted net earnings per share | FY2023 | $4.80 – $5.05 | Reaffirmed |
| Apr 25, 2023 | Net earnings | FY2023 | $4.57 – $4.81 | New |
| Apr 25, 2023 | Adjusted free cash flow | FY2023 | $230.00M – $250.00M | Reaffirmed |
| Apr 25, 2023 | Operating income | FY2023 | $302.00M – $321.00M | New |
| Apr 25, 2023 | Adjusted operating income | FY2023 | $312.00M – $332.00M | New |
| Apr 25, 2023 | Net sales | FY2023 | $1.26B – $1.31B | Reaffirmed |
| Feb 21, 2023 | Adjusted EBITDA | FY2023 | $395.00M – $420.00M | New |
| Feb 21, 2023 | Adjusted diluted earnings per share | FY2023 | $4.80 – $5.05 | New |
| Feb 21, 2023 | Adjusted free cash flow | FY2023 | $230.00M – $250.00M | New |
| Feb 21, 2023 | Net sales | FY2023 | $1.26B – $1.31B | New |
| Oct 25, 2022 | Adjusted EBITDA | FY2022 | $385.00M – $395.00M | Lowered |
| Oct 25, 2022 | Adjusted diluted earnings per share | FY2022 | $4.75 – $4.85 | Lowered |
| Oct 25, 2022 | Adjusted free cash flow | FY2022 | $210.00M – $220.00M | Lowered |
| Oct 25, 2022 | Net sales | FY2022 | $1.22B – $1.24B | Lowered |
| Jul 26, 2022 | Adjusted EBITDA | FY2022 | $410.00M – $420.00M | Lowered |
| Jul 26, 2022 | Adjusted diluted earnings per share | FY2022 | $5.10 – $5.20 | Raised |
| Jul 26, 2022 | Adjusted free cash flow | FY2022 | $215.00M – $235.00M | Reaffirmed |
| Jul 26, 2022 | Net sales | FY2022 | $1.23B – $1.25B | Narrowed |
| Apr 26, 2022 | Adjusted EBITDA | FY2022 | $410.00M – $430.00M | Reaffirmed |
| Apr 26, 2022 | Adjusted diluted earnings per share | FY2022 | $5.00 – $5.20 | Reaffirmed |
| Apr 26, 2022 | Adjusted free cash flow | FY2022 | $215.00M – $235.00M | Reaffirmed |
| Apr 26, 2022 | Net sales | FY2022 | $1.22B – $1.26B | Reaffirmed |
| Feb 22, 2022 | Adjusted EBITDA | FY2022 | $410.00M – $430.00M | New |
| Feb 22, 2022 | Adjusted diluted earnings per share | FY2022 | $5.00 – $5.20 | New |
| Feb 22, 2022 | Adjusted free cash flow | FY2022 | $215.00M – $235.00M | New |
| Feb 22, 2022 | Net sales | FY2022 | $1.22B – $1.26B | New |
| Oct 26, 2021 | Adjusted EBITDA | FY2021 | $372.00M – $378.00M | New |
| Oct 26, 2021 | Adjusted diluted earnings per share | FY2021 | $4.25 – $4.35 | New |
| Oct 26, 2021 | Adjusted free cash flow | FY2021 | $198.00M – $208.00M | New |
| Oct 26, 2021 | Net Sales | FY2021 | $1.10B – $1.11B | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Armstrong World Industries filed with the SEC as exhibits to Form 8-K or 6-K
- Update
- Update
- Results
- Results
- News
- Update
- News
- Results
- Results
- News
- Update
- Update
- Results
- Results
- News
See a number that looks wrong?